Trademark: 97060830
Word
QZEK
Status
Registered
Status Code
700
Status Date
Tuesday, November 29, 2022
Serial Number
97060830
Registration Number
6910676
Registration Date
Tuesday, November 29, 2022
Mark Type
4000
Filing Date
Tuesday, October 5, 2021
Published for Opposition
Tuesday, September 13, 2022

Trademark Owner History
Glaxo Group Limited - Original Registrant

Classifications
5 Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Trademark Events
Nov 29, 2022
Notice Of Registration Confirmation Emailed
Nov 29, 2022
Registered-Principal Register
Nov 9, 2022
Teas Change Of Correspondence Received
Nov 9, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 9, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 13, 2022
Official Gazette Publication Confirmation E-Mailed
Sep 13, 2022
Published For Opposition
Aug 24, 2022
Notification Of Notice Of Publication E-Mailed
Aug 5, 2022
Approved For Pub - Principal Register
Jul 11, 2022
Examiner's Amendment Entered
Jul 11, 2022
Assigned To Lie
Jul 10, 2022
Notification Of Examiners Amendment E-Mailed
Jul 10, 2022
Examiners Amendment E-Mailed
Jul 10, 2022
Examiners Amendment -Written
Jul 7, 2022
Assigned To Examiner
Oct 29, 2021
New Application Office Supplied Data Entered In Tram
Oct 8, 2021
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24